MiNA Therapeutics
- Org chart
- Peter Bains
Peter Bains
Chief Business Officer
Peter was appointed Chief Business Officer in 2020 after serving several years as a Non Executive Director. Peter brings three decades of experience in the global pharmaceutical space. Peter has held multiple leadership roles in biopharmaceuticals, most recently as Chief Executive Officer of Sosei Heptares (TSE:4565) and Syngene International (N...
Roles at MiNA Therapeutics
Chief Business Officer
Current role
My work style
How I prefer to work
Qualities I value in my colleagues
Sign up to see more about the team at MiNA Therapeutics
My pet peeves
My communication style
Teams
No teams
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.